Altamira Therapeutics Ltd. — NT 20-F Filings
1 NT 20-F filing on record
This page lists all NT 20-F filings submitted to the SEC by Altamira Therapeutics Ltd. (CYTOF), sorted by most recent first. Each row links to the full filing on EdgarLookup. Altamira Therapeutics Ltd. has filed 1 NT 20-F document with the SEC since 2014. To view all SEC filings by Altamira Therapeutics Ltd., see the full filings list.
All
15-12G
15F-12B
20-F
20-F/A
25-NSE
424B3
424B4
424B5
6-K
6-K/A
8-A12B
8-A12B/A
8-K12G3
CERT
CERTNAS
CORRESP
CT ORDER
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
F-4
F-4/A
FWP
NT 20-F
POS AM
POS EX
RW
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| NT 20-F | NOTIFICATION OF LATE FILING | 0001213900-23-034751 | May 1, 2023 | Dec 31, 2022 |